Truveta welcomes Rod Hochman, MD, president and CEO of Providence, as new Truveta Board of Directors Chair
13 mai 2024 09h00 HE
|
Truveta
BELLEVUE, Wash., May 13, 2024 (GLOBE NEWSWIRE) -- Today Truveta, a growing collective of more than 30 health systems with a mission of Saving Lives with Data, welcomes Rod Hochman, MD, president and...
Using clinical-led AI, Truveta expands clinical notes and medical images available to advance research
02 mai 2024 09h00 HE
|
Truveta
BELLEVUE, Wash., May 02, 2024 (GLOBE NEWSWIRE) -- Today Truveta announced the availability of expanded concepts from clinical notes -- including family history, medication details reported to...
Truveta delivers largest and most complete mother and child EHR dataset to advance healthcare
25 avr. 2024 09h00 HE
|
Truveta
BELLEVUE, Wash., April 25, 2024 (GLOBE NEWSWIRE) -- Truveta, the company with a mission of Saving Lives with Data, announced today the largest and most complete mother-child electronic health record...
Truveta Research on increased speech delays in children during the pandemic published in JAMA Pediatrics
05 déc. 2023 09h00 HE
|
Truveta
BELLEVUE, Wash., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new research published in JAMA Pediatrics exploring the incidence of first-time speech delays in children under the age of...
Truveta welcomes Patrick Caubel, Pfizer Chief Safety Officer, to its Board of Directors
04 déc. 2023 09h00 HE
|
Truveta
BELLEVUE, Wash., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Truveta, the company with a mission of saving lives with data, welcomes its first member from the life science industry to its Board of Directors....
Largest real-world study finds tirzepatide (Mounjaro) up to three times more effective than semaglutide (Ozempic) for weight loss
27 nov. 2023 09h00 HE
|
Truveta
BELLEVUE, Wash., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new comparative effectiveness research exploring weight loss among patients taking semaglutide (Ozempic) and tirzepatide...
Truveta announces availability of millions of echocardiogram reports to advance cardiovascular research
08 nov. 2023 09h00 HE
|
Truveta
BELLEVUE, Wash., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced the availability of more than 56.6 million clinical observations from more than 2.7 million echocardiogram reports from...
More than 50 organizations choose Truveta for the most complete, timely, and clean EHR data to study safety and effectiveness, improve patient care, and train medical AI
23 oct. 2023 09h00 HE
|
Truveta
Bellevue, WASH., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Truveta announced today that it is partnering with more than 50 organizations in life sciences, healthcare, government, academic medical centers,...
Medical Components Inc. and Truveta partner to advance care for patients living with cancer and chronic kidney disease
12 sept. 2023 09h00 HE
|
Truveta
BELLEVUE, Wash., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Medical Components, Inc. is partnering with Truveta to advance the use of real-world data to improve clinical care for patients battling cancer...
Registration Now Open for 2024 MDA Clinical & Scientific Conference, to Showcase Cutting Edge Research Advancements and Clinical Achievements in Neuromuscular Disease
09 août 2023 10h35 HE
|
Muscular Dystrophy Association
New York, Aug. 09, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA), convener of the largest worldwide gathering of the neuromuscular disease community, announced today that...